immune related adverse events new drugs new trouble

This presentation explores immune-related adverse events (irAEs) in the context of emerging therapeutics, focusing on their definition, impact, and prevalence. It examines the mechanisms, patient susceptibility, and challenges posed by new immune-modulating drugs, including adverse outcomes and regulatory considerations. Strategies for clinical management, such as early detection and innovative interventions, are discussed alongside future efforts to develop safer therapies, improve...